Oncotarget Epigenetics and Immunotherapy Combined Fights Rare Lymphoma In a new Oncotarget study, researchers assessed an epigenetic and immunotherapy treatment regimen among patients... read more August 24, 2022
Oncotarget Exploration of Gene Editing In The Tumor Setting Researchers repurposed CRISPR/Cas9 epigenetic editing technology in hopes of characterizing transcriptional changes and effects... read more October 5, 2021
Oncotarget Behind the Study: Populations of Cells Resistant to EMT Dr. Herbert Levine and Dr. Mohit Kumar Jolly describe their research that... read more September 27, 2021
Oncotarget Mechanisms Identified as Contributors to Metastasis in Ewing’s Sarcoma Researchers from Colorado published a study identifying potential mechanisms involved in the higher rate of... read more October 27, 2020